Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice.

Jung, Gwon Soo; Jeon, Jae Han; Choe, Mi Sun; Kim, Sung Woo; Lee, In Kyu; Kim, Mi Kyung; Park, Keun Gyu

Jung, Gwon Soo; Jeon, Jae Han; Choe, Mi Sun; Kim, Sung Woo; Lee, In Kyu; Kim, Mi Kyung; Park, Keun Gyu.

Afiliación

Jung GS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Jeon JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Choe MS; Department of Pathology, Keimyung University School of Medicine, Daegu, Korea.
Kim SW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Lee IK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Kim MK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. mdkmk@dsmc.or.kr.
Park KG; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea. kpark@knu.ac.kr.

Diabetes Metab J ; 40(3): 211-21, 2016 Jun.

Article en En | MEDLINE | ID: mdl-27098503

Palabras clave

DPP-4 inhibitor; Diabetes mellitus, type 1; Renal fibrosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Metab J Año: 2016 Tipo del documento: Article Pais de publicación: